Ceren Suntur
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ceren Suntur has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ali Murat Tatli
Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya 07000, Türkiye
1 shared publication - Hasan Şenol Coşkun
Akdeniz University
1 shared publication - Havva Serap Toru
Department of Pathology, Akdeniz University, School of Medicine, Antalya, Turkey
1 shared publication - Onur Ertunc
Department of Pathology The Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publication - Sema Sezgin Goksu
AKDENİZ ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, TIBBİ ONKOLOJİ BİLİM DALI
1 shared publication Yusuf İlHan
Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkiye
1 shared publication
Latest Publications
- 1 January 2023
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 3 (1) , 40-43
Primary Ewing Sarcoma of the Kidney in a 54-Year-Old Male: A Rare Case Report
Ewing sarcomas/Primitive neuroectodermal tumors are aggressive tumors, typically seen in children and young adults. These tumors are of neuroectodermal origin and, also known as Ewing sarcoma family tumors. They are most commonly seen in the bones and soft tissues. Primary Ewing sarcoma of the kidney is rarely seen. It has nonspecific symptoms and imaging findings. Therefore, it is mostly diagnosed postoperatively. Its diagnosis is based on histological morphology, immunohistochemistry and, molecular genetic tests. A multi-modality treatment approach is very important. Here, we presented a male patient with primary Ewing sarcoma of the kidney, relatively in older age. A 54-year-old male patient admitted to the hospital with right flank pain and hematuria. He was operated successfully and than received adjuvant vincristine, doxorubicin, cyclophosphamide, and ifosfamide, etoposide chemotherapy regimens. No treatment-related toxicity was observed and the patient is still in remission. Despite using surgery and adjuvant chemotherapy in treatment, because of its rarity there was no randomized trial about kidney Ewing sarcomas. These rare tumors still need robust therapeutic treatment regimens.
- 1 January 2023
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 3 (1) , 40-43
Primary Ewing Sarcoma of the Kidney in a 54-Year-Old Male: A Rare Case Report
Ewing sarcomas/Primitive neuroectodermal tumors are aggressive tumors, typically seen in children and young adults. These tumors are of neuroectodermal origin and, also known as Ewing sarcoma family tumors. They are most commonly seen in the bones and soft tissues. Primary Ewing sarcoma of the kidney is rarely seen. It has nonspecific symptoms and imaging findings. Therefore, it is mostly diagnosed postoperatively. Its diagnosis is based on histological morphology, immunohistochemistry and, molecular genetic tests. A multi-modality treatment approach is very important. Here, we presented a male patient with primary Ewing sarcoma of the kidney, relatively in older age. A 54-year-old male patient admitted to the hospital with right flank pain and hematuria. He was operated successfully and than received adjuvant vincristine, doxorubicin, cyclophosphamide, and ifosfamide, etoposide chemotherapy regimens. No treatment-related toxicity was observed and the patient is still in remission. Despite using surgery and adjuvant chemotherapy in treatment, because of its rarity there was no randomized trial about kidney Ewing sarcomas. These rare tumors still need robust therapeutic treatment regimens.